Kyung-Min Lee
Overview
Explore the profile of Kyung-Min Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
3244
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim Y, Jang E, Hwang J, Lee K, Xayaheuang S, Choi S, et al.
Hum Vaccin Immunother
. 2024 Nov;
20(1):2428516.
PMID: 39610025
The COVID-19 pandemic forced the rapid development of methods to measure humoral and cellular immunity against SARS-CoV-2. The lack of a global standardized protocol and the high variability of intra-...
2.
Chica-Parrado M, Kim G, Uemoto Y, Napolitano F, Lin C, Ye D, et al.
Cancer Lett
. 2024 Sep;
604:217219.
PMID: 39244005
Luminal Androgen Receptor (LAR) triple-negative breast cancers (TNBC) express androgen receptors (AR), exhibit high frequency of PIK3CA mutations and intact RB. Herein, we investigated combined blockade of the CDK4/6 and...
3.
Lee J, Shim J, Lim M, Baek C, Jeon B, Cho M, et al.
Comput Biol Med
. 2024 Mar;
173:108309.
PMID: 38520923
Background: Patient isolation units (PIUs) can be an effective method for effective infection control. Computational fluid dynamics (CFD) is commonly used for PIU design; however, optimizing this design requires extensive...
4.
Lin C, Chang T, Wang Y, Guo L, Gao Y, Bikorimana E, et al.
Nat Commun
. 2024 Mar;
15(1):2287.
PMID: 38480701
CDK4/6 inhibitors (CDK4/6i) have improved survival of patients with estrogen receptor-positive (ER+) breast cancer. However, patients treated with CDK4/6i eventually develop drug resistance and progress. RB1 loss-of-function alterations confer resistance...
5.
Kim H, Son S, Ko Y, Lim H, Lee J, Lee K, et al.
Carcinogenesis
. 2024 Mar;
45(7):510-519.
PMID: 38446998
Cysteine-rich angiogenic inducer 61 (CYR61) is a protein from the CCN family of matricellular proteins that play diverse regulatory roles in the extracellular matrix. CYR61 is involved in cell adhesion,...
6.
Lee J, Choi J, Lee K, Lee M, Ku J, Oh D, et al.
Biomol Ther (Seoul)
. 2023 Dec;
32(1):123-135.
PMID: 38148558
Although gemcitabine-based regimens are widely used as an effective treatment for pancreatic cancer, acquired resistance to gemcitabine has become an increasingly common problem. Therefore, a novel therapeutic strategy to treat...
7.
Kim Y, Qin J, Baek I, Lee K, Kim S, Kim S, et al.
Curr Res Food Sci
. 2023 Dec;
7:100647.
PMID: 38077468
Consumption of aflatoxin-contaminated food can cause severe illness when consumed by humans or livestock. Because the mycotoxin frequently occurs in cereal grains and other agricultural crops, it is crucial to...
8.
Lee K, Herrman T
Food Addit Contam Part A Chem Anal Control Expo Risk Assess
. 2023 Dec;
41(1):33-44.
PMID: 38039334
Commercial animal feed in Texas was characterized by determining natural gamma emitters including K,Cs, and Uranium (U and U) and Thorium (Th) series to obtain basic radioactivity values. The measured...
9.
Kim Y, Baek I, Lee K, Kim G, Kim S, Kim S, et al.
Toxins (Basel)
. 2023 Jul;
15(7).
PMID: 37505741
Aflatoxins and fumonisins, commonly found in maize and maize-derived products, frequently co-occur and can cause dangerous illness in humans and animals if ingested in large amounts. Efforts are being made...
10.
Lin C, Chang T, Wang Y, Guo L, Gao Y, Bikorimana E, et al.
Res Sq
. 2023 Jul;
PMID: 37502925
CDK4/6 inhibitors (CDK4/6i) have improved survival of patients with estrogen receptor-positive (ER+) breast cancer. However, patients treated with CDK4/6i eventually develop drug resistance and progress. loss-of-function alterations confer acquired resistance...